MarketAlert – Real-Time Market & Crypto News, Analysis & AlertsMarketAlert – Real-Time Market & Crypto News, Analysis & Alerts
Font ResizerAa
  • Crypto News
    • Altcoins
    • Bitcoin
    • Blockchain
    • DeFi
    • Ethereum
    • NFTs
    • Press Releases
    • Latest News
  • Blockchain Technology
    • Blockchain Developments
    • Blockchain Security
    • Layer 2 Solutions
    • Smart Contracts
  • Interviews
    • Crypto Investor Interviews
    • Developer Interviews
    • Founder Interviews
    • Industry Leader Insights
  • Regulations & Policies
    • Country-Specific Regulations
    • Crypto Taxation
    • Global Regulations
    • Government Policies
  • Learn
    • Crypto for Beginners
    • DeFi Guides
    • NFT Guides
    • Staking Guides
    • Trading Strategies
  • Research & Analysis
    • Blockchain Research
    • Coin Research
    • DeFi Research
    • Market Analysis
    • Regulation Reports
Reading: Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences
Share
Font ResizerAa
MarketAlert – Real-Time Market & Crypto News, Analysis & AlertsMarketAlert – Real-Time Market & Crypto News, Analysis & Alerts
Search
  • Crypto News
    • Altcoins
    • Bitcoin
    • Blockchain
    • DeFi
    • Ethereum
    • NFTs
    • Press Releases
    • Latest News
  • Blockchain Technology
    • Blockchain Developments
    • Blockchain Security
    • Layer 2 Solutions
    • Smart Contracts
  • Interviews
    • Crypto Investor Interviews
    • Developer Interviews
    • Founder Interviews
    • Industry Leader Insights
  • Regulations & Policies
    • Country-Specific Regulations
    • Crypto Taxation
    • Global Regulations
    • Government Policies
  • Learn
    • Crypto for Beginners
    • DeFi Guides
    • NFT Guides
    • Staking Guides
    • Trading Strategies
  • Research & Analysis
    • Blockchain Research
    • Coin Research
    • DeFi Research
    • Market Analysis
    • Regulation Reports
Have an existing account? Sign In
Follow US
© Market Alert News. All Rights Reserved.
  • bitcoinBitcoin(BTC)$70,608.005.16%
  • ethereumEthereum(ETH)$2,049.454.82%
  • tetherTether(USDT)$1.000.02%
  • binancecoinBNB(BNB)$647.223.79%
  • rippleXRP(XRP)$1.392.66%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$88.365.00%
  • tronTRON(TRX)$0.2833000.58%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.030.25%
  • dogecoinDogecoin(DOGE)$0.0912161.24%
Global Regulations

Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences

Last updated: August 25, 2025 2:00 pm
Published: 6 months ago
Share

PRNewswire

Bengaluru (Karnataka) [India], August 25: Canarys (ISIN: INE0QG301017) is proud to announce the launch of Auryis, their AI-powered, unified compliance assessment platform purpose-built for Pharma and Life Sciences. This marks a pivotal step in Canarys’ evolution–from a services-led organization to a product-led company.

In a fast-changing regulatory landscape, Auryis delivers real-time, structured, and audit-ready compliance insights across all digital content–including SOPs, clinical trial documents, training materials, and marketing assets. It intelligently maps each element to external regulations (GxP, FDA, EMA), internal standards, and custom business rules–helping organizations anticipate and mitigate non-compliance risk before it escalates.

What sets Auryis apart:

– Seamless content assessment: Ingests and analyses diverse formats, linking content to specific regulatory requirements.

– Automated noncompliance detection: Flags non-compliance risks instantly and prioritizes critical issues for rapid resolution.

– Human-in-the-loop intelligence: Enables SME review and feedback to continuously refine AI precision.

– Custom rule integration: Adapts quickly to new policies, study conditions, and temporary guidance.

– Continuous learning: Keeps pace with evolving global regulations, reducing manual workload and review cycles.

CEO, Canarys, Sheshadri Srinivas commented: “In today’s complex regulatory environment, Pharma and Life Sciences organizations face mounting pressure–manual reviews, rapidly shifting global standards, and the costly consequences of compliance gaps that can delay approvals and impact patient safety.

Auryis addresses these challenges head-on, transforming compliance into a faster, smarter, and continuous process. Powered by AI and reinforced by expert validation, it delivers audit-ready insights, lowers non-compliance risk, and drives operational excellence.

This launch is a defining milestone in Canarys’ journey. With Auryis, we are stepping confidently into a product-led future–creating durable value for our clients, investors, and partners.”

Business impact at a glance:

Read more on Sri Lanka Source

This news is powered by Sri Lanka Source Sri Lanka Source

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading...

Related

Ban, regulate or reform? Social media & under-15s – The India question – THE LOCAL REPORT ARTICLES
China suggests lasers and stealth submarines to counter Elon Musk’s Starlink satellites
Lundin Mining Announces 2025 Production Results and 2026 Guidance
Afreximbank convenes Abidjan summit to unlock trade finance for SMEs
Yubico’s Report in Line with Preliminary Announcement

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Email Copy Link Print
Previous Article Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences
Next Article Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences
© Market Alert News. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Prove your humanity


Lost your password?

%d